S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Better Than Oil Stocks (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Better Than Oil Stocks (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Laser breakthrough could send stock soaring 2,467% (Ad)
Disney, DeSantis legal fights ratchet up as company demands documents from Florida governor
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Better Than Oil Stocks (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Better Than Oil Stocks (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Laser breakthrough could send stock soaring 2,467% (Ad)
Disney, DeSantis legal fights ratchet up as company demands documents from Florida governor
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Better Than Oil Stocks (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Better Than Oil Stocks (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Laser breakthrough could send stock soaring 2,467% (Ad)
Disney, DeSantis legal fights ratchet up as company demands documents from Florida governor
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Better Than Oil Stocks (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Better Than Oil Stocks (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Laser breakthrough could send stock soaring 2,467% (Ad)
Disney, DeSantis legal fights ratchet up as company demands documents from Florida governor
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
NASDAQ:RDNT

RadNet (RDNT) Stock Forecast, Price & News

$28.19
-0.51 (-1.78%)
(As of 09/29/2023 ET)
Compare
Today's Range
$27.86
$28.87
50-Day Range
$27.30
$34.47
52-Week Range
$12.03
$35.18
Volume
823,875 shs
Average Volume
563,613 shs
Market Capitalization
$1.91 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$33.33

RadNet MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
18.2% Upside
$33.33 Price Target
Short Interest
Healthy
2.48% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.52
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
7.89%
From $0.38 to $0.41 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.15 out of 5 stars

Medical Sector

481st out of 972 stocks

Medical Laboratories Industry

13th out of 25 stocks


RDNT stock logo

About RadNet (NASDAQ:RDNT) Stock

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

RDNT Price History

RDNT Stock News Headlines

This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Jim Cramer Says This Major Telecom Stock Is 'Horrendous'
RadNet (RDNT) Q2 Earnings and Revenues Top Estimates
A Preview Of RadNet's Earnings
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Why RadNet (RDNT) Stock Is Getting Hammered
RadNet Shares Fall After Pricing Stock Offering
Raymond James Keeps Their Buy Rating on Radnet (RDNT)
RadNet earnings: here's what Wall Street expects
See More Headlines
Receive RDNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter.

RDNT Company Calendar

Last Earnings
8/08/2023
Today
10/01/2023
Next Earnings (Estimated)
11/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:RDNT
Employees
9,067
Year Founded
1980

Price Target and Rating

Average Stock Price Forecast
$33.33
High Stock Price Forecast
$40.00
Low Stock Price Forecast
$30.00
Forecasted Upside/Downside
+18.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$10.65 million
Pretax Margin
1.09%

Debt

Sales & Book Value

Annual Sales
$1.43 billion
Cash Flow
$3.48 per share
Book Value
$8.57 per share

Miscellaneous

Free Float
64,771,000
Market Cap
$1.91 billion
Optionable
Optionable
Beta
1.68

Social Links

The Best High-Yield Dividend Stocks for 2023 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Dr. Howard G. Berger M.D. (Age 77)
    Chairman, Pres & CEO
    Comp: $5.56M
  • Mr. Mark D. Stolper (Age 52)
    Exec. VP & CFO
    Comp: $1.13M
  • Mr. Mital Patel (Age 37)
    Exec. VP of Financial Planning & Analysis and Chief Admin. Officer
    Comp: $1.15M
  • Mr. Norman R. HamesMr. Norman R. Hames (Age 67)
    Pres & COO of Western Operations
    Comp: $1.28M
  • Mr. Stephen M. Forthuber (Age 62)
    Pres & COO of Eastern Operations
    Comp: $1.3M
  • Ms. Christine Nayoma Gordon (Age 60)
    Sr. VP of Operations - Northern California & Director
    Comp: $384.38k
  • Mr. Ranjan Jayanathan (Age 67)
    Exec. VP, Chief Information Officer & GM of eRAD - Radiology Information Technology Division
  • Dr. Gregory Sorensen M.D. (Age 61)
    Exec. VP, Chief Science Officer & Director
  • Ms. Laura Foster BSRT
    MPH, J.D., Sr. VP of Compliance & Regulatory Affairs
  • Mr. David Jeffrey Katz (Age 58)
    Exec. VP, Chief Legal Officer & Corp. Sec.













RDNT Stock - Frequently Asked Questions

Should I buy or sell RadNet stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for RadNet in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" RDNT shares.
View RDNT analyst ratings
or view top-rated stocks.

What is RadNet's stock price forecast for 2023?

3 brokerages have issued 1-year price objectives for RadNet's stock. Their RDNT share price forecasts range from $30.00 to $40.00. On average, they anticipate the company's share price to reach $33.33 in the next year. This suggests a possible upside of 18.2% from the stock's current price.
View analysts price targets for RDNT
or view top-rated stocks among Wall Street analysts.

How have RDNT shares performed in 2023?

RadNet's stock was trading at $18.83 at the beginning of 2023. Since then, RDNT stock has increased by 49.7% and is now trading at $28.19.
View the best growth stocks for 2023 here
.

When is RadNet's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 8th 2023.
View our RDNT earnings forecast
.

How were RadNet's earnings last quarter?

RadNet, Inc. (NASDAQ:RDNT) issued its quarterly earnings results on Tuesday, August, 8th. The medical research company reported $0.24 earnings per share for the quarter, topping analysts' consensus estimates of $0.07 by $0.17. The medical research company had revenue of $403.70 million for the quarter, compared to the consensus estimate of $389.29 million. RadNet had a negative net margin of 0.84% and a positive trailing twelve-month return on equity of 3.98%. The firm's revenue for the quarter was up 13.9% compared to the same quarter last year. During the same period in the prior year, the company earned $0.15 earnings per share.

What guidance has RadNet issued on next quarter's earnings?

RadNet issued an update on its FY 2023 earnings guidance on Tuesday, August, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.57 billion-$1.61 billion, compared to the consensus revenue estimate of $1.54 billion.

What is Howard G. Berger's approval rating as RadNet's CEO?

174 employees have rated RadNet Chief Executive Officer Howard G. Berger on Glassdoor.com. Howard G. Berger has an approval rating of 45% among the company's employees. This puts Howard G. Berger in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of RadNet own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RadNet investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), OPKO Health (OPK), Boeing (BA), Rigel Pharmaceuticals (RIGL), UnitedHealth Group (UNH), Pfizer (PFE) and AT&T (T).

What is RadNet's stock symbol?

RadNet trades on the NASDAQ under the ticker symbol "RDNT."

How do I buy shares of RadNet?

Shares of RDNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is RadNet's stock price today?

One share of RDNT stock can currently be purchased for approximately $28.19.

How much money does RadNet make?

RadNet (NASDAQ:RDNT) has a market capitalization of $1.91 billion and generates $1.43 billion in revenue each year. The medical research company earns $10.65 million in net income (profit) each year or ($0.25) on an earnings per share basis.

How many employees does RadNet have?

The company employs 9,067 workers across the globe.

How can I contact RadNet?

RadNet's mailing address is 1510 COTNER AVE, LOS ANGELES CA, 90025. The official website for the company is www.radnet.com. The medical research company can be reached via phone at (310) 445-2800, via email at investorrelations@radnet.com, or via fax at 310-445-2980.

This page (NASDAQ:RDNT) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -